Kernebeck Patentanwalts competitive analysis

Explore patent oppositions filed by Kernebeck Patentanwalts against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2026
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEIGENEAug 5, 2026
Mavacamten For Use In The Treatment Of Hypertrophic CardiomyopathyMYOKARDIAJun 17, 2026
Use Of A Combination Comprising A Btk Inhibitor For Treating CancersBEIGENESep 13, 2024
Diamine Oxidase For Use In The Treatment Or Prevention Of Attention Deficit Hyperactivity Disorder (Adhd)DR HEALTHCARE ESPAAOct 27, 2017
Composition Comprising Diamine Oxidase For The Prevention Of Hangover SymptomsDR HEALTHCARE ESPAASep 14, 2017

Latest PTAB cases involving Kernebeck Patentanwalts

Discover the latest PTAB cases involving Kernebeck Patentanwalts, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Kernebeck Patentanwalts with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KERNEBECK PATENTANWALTS6 - - -
BEIGENE - 7 - -
BEIGENE SWITZERLAND - 7 - -
DR HEALTHCARE ESPAA - 2 - -